0001140361-22-023335.txt : 20220616
0001140361-22-023335.hdr.sgml : 20220616
20220616205626
ACCESSION NUMBER: 0001140361-22-023335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGUIRE TERRANCE
CENTRAL INDEX KEY: 0001117003
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 221022213
MAIL ADDRESS:
STREET 1: C/O POLARIS VENTURE PARTNERS LP
STREET 2: 1000 WINTER STREET, SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02154
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4.xml
FORM 4
X0306
4
2022-06-14
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001117003
MCGUIRE TERRANCE
C/O CYCLERION THERAPEUTICS, INC.
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
true
Stock Option (Right to Buy)
0.53
2022-06-14
4
A
0
20000
0
A
2032-06-14
Common Stock
20000
20000
D
The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
/s/ Gary J. Simon, Attorney-in-Fact
2022-06-16